The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127070481 12707048 1 I 20140607 20140611 20160901 20160901 EXP US-PFIZER INC-2014160141 PFIZER 55.00 YR M Y 120.00000 KG 20160901 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127070481 12707048 1 PS IBUPROFEN. IBUPROFEN 1 Oral UNK UNK, 3X/DAY Y 18989 TABLET TID
127070481 12707048 2 SS IBUPROFEN. IBUPROFEN 1 Y 18989 TABLET
127070481 12707048 3 SS METFORMIN HCL METFORMIN HYDROCHLORIDE 1 Oral 1000 MG, 2X/DAY 6028000 MG Y 0 1000 MG BID
127070481 12707048 4 SS LISINOPRIL. LISINOPRIL 1 Oral 20 MG, DAILY Y 0 20 MG
127070481 12707048 5 SS BACTRIM DS SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 1 DF (TAB 800/160MG), 2X/DAY 8 DF Y 0 1 DF BID
127070481 12707048 6 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 40 MG, 1X/DAY 0 40 MG QD
127070481 12707048 7 C NIACIN. NIACIN 1 Oral 500 MG, DAILY 0 500 MG
127070481 12707048 8 C FISH OIL FISH OIL 1 Oral 4000 MG, DAILY 0 4000 MG
127070481 12707048 9 C TRAMADOL. TRAMADOL 1 Oral 100 MG, EVERY 6 HOURS 0 100 MG
127070481 12707048 10 C CELEXA CITALOPRAM HYDROBROMIDE 1 Oral 40 MG, DAILY 0 40 MG
127070481 12707048 11 C ATENOLOL. ATENOLOL 1 Oral 25 MG, DAILY 0 25 MG
127070481 12707048 12 C FLEXERIL CYCLOBENZAPRINE HYDROCHLORIDE 1 Oral 10 MG, 3X/DAY 0 10 MG TID
127070481 12707048 13 C TRADJENTA LINAGLIPTIN 1 Oral 5 MG, DAILY 0 5 MG
127070481 12707048 14 C GEMFIBROZIL. GEMFIBROZIL 1 Oral 600 MG, 2X/DAY 0 600 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127070481 12707048 1 Osteoarthritis
127070481 12707048 2 Rheumatoid arthritis
127070481 12707048 3 Type 2 diabetes mellitus
127070481 12707048 4 Hypertension
127070481 12707048 5 Urinary tract infection
127070481 12707048 6 Prophylaxis
127070481 12707048 7 Hyperlipidaemia
127070481 12707048 8 Hyperlipidaemia
127070481 12707048 9 Osteoarthritis
127070481 12707048 10 Depression
127070481 12707048 11 Hypertension
127070481 12707048 12 Osteoarthritis
127070481 12707048 13 Type 2 diabetes mellitus
127070481 12707048 14 Blood triglycerides increased

Outcome of event

Event ID CASEID OUTC COD
127070481 12707048 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127070481 12707048 Acute kidney injury

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127070481 12707048 1 20111124 20140601 0
127070481 12707048 3 20060308 20140608 0
127070481 12707048 4 20060516 20140608 0
127070481 12707048 5 20140604 20140607 0
127070481 12707048 6 20111124 20140601 0
127070481 12707048 7 20071219 20140608 0
127070481 12707048 8 20071010 20140608 0
127070481 12707048 9 20060308 20140608 0
127070481 12707048 10 20060516 20140608 0
127070481 12707048 11 20060516 0
127070481 12707048 12 20060808 0
127070481 12707048 13 20120405 0
127070481 12707048 14 20131219 0